Elliott S J, Salcedo J R
Urology. 1985 Jul;26(1):20-1. doi: 10.1016/0090-4295(85)90247-x.
Aminocaproic acid (EACA) was used in 2 patients with cadaveric renal allografts because gross hematuria developed after percutaneous renal biopsies. Marked improvement was noted within twelve hours with no recurrence after discontinuation of EACA. EACA was effective in moderate renal failure.